Company & Sponsor Intelligence

Samsung Medical Center

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials9

Recruiting0

Completed5

Countries1

Therapeutic footprint

alzheimersdepressionmigraine_headachemovement_disordersparkinsonsstroke

Indexed studies

NCT01309776Comparison of Tianeptine Versus Escitalopram Patients Major Depressive Disorder
depression · South KoreaPHASE4

NCT04903457The Effect of tDCS on Motor Learning and Neural Network in Stroke Patients
stroke · South KoreaNA

NCT02983838Research on Pathophysiology and Treatment in Depression Using Brain Derived Neurotrophic Factor and Amyloid Neuroimaging
alzheimers · South KoreaUNKNOWN

NCT04595578Cerebellar rTMS and Physical Therapy for Cerebellar Ataxia
movement_disorders · South KoreaNA

NCT02227953A Pilot Study of tDCS for Mild to Moderate Alzhemier's Disease
alzheimers · South KoreaNA

NCT01198093Clinical Research Center for Dementia of South Korea (CREDOS)(or CRCD)
alzheimers · South KoreaUNKNOWN

NCT01023867Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia
alzheimers · South KoreaNA

NCT03494673Prediction of WMH in Migraine Using a BOLD-CVR Map
migraine_headache · South KoreaUNKNOWN

NCT02850159Effect of Simultaneous Dual Stimulation on Freezing of Gait in Parkinson's Disease
parkinsons · NA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →